CCL22 production by tumor cells was identified as a mechanism of immune escape in breast cancer, through CCR4+ Treg recruitment in the tumor microenvironment (TME), induced by IFNγ exposure [34, 35]. This evidence concerns the gene CCR4 and breast cancer.